Analysis
Jumpstarted: Investors target China's EV charging networks
Telaidian’s recent Series A round underlines the opportunities in China’s electric vehicle charging space. While growth seems certain, some industry dynamics have yet to play out
Portfolio: Capital Square Partners and Aegis/StarTek
Capital Square Partners’ acquisition of Indian business processing outsourcing (BPO) player Aegis ultimately helped two different companies find global relevance after a turbulent and disruptive decade
China LP defaults: Battle of wills
A protracted legal dispute between a cross-border private equity firm and a Chinese investor is a reminder of the difficulties that can arise over fund defaults. Negotiation is always the preferred course of action
Coronavirus & secondaries: Niche dilemmas
Anecdotal feedback from secondaries professionals reveals a quick onset of stagnation in the market due to COVID-19. Creative workarounds are not impossible, but almost
GP profile: GTJA Investment Group
Having established itself as a leading player in the renminbi space, China healthcare sector specialist GTJA Investment Group now wants to prove its worth to overseas LPs
Coronavirus & leverage: Room to maneuver?
Economic disruption caused by the coronavirus outbreak is likely to leave many private equity portfolio companies in breach of their leverage covenants. Borrowers and lenders are looking for a fix
PE targets sensual wellness: Good vibrations
A recent commitment by China’s CDH Investments to Wow Tech underlines how sensual health products such as vibrators are moving from the margins to the mainstream, globally and in Asia
Retail investment in PE: Common stock
Signs are converging that increased retail investor participation in private equity is inevitable. Myriad roadblocks around access, alignment, and infrastructure will inhibit the transition
Coronavirus & fundraising: Caught in a bind
The coronavirus outbreak has implications for PE fundraising well beyond China. Many Asia-based managers are either unable to go and see LPs or LPs are not permitted to visit them
Coronavirus in Asia: Ongoing analysis
Coronavirus concerns among GPs not solely focused on China vary based on their direct or indirect exposure to China, but gauging private equity responses to the crisis is like chasing a moving target
Coronavirus in China: Back from the brink
China GPs are trying to navigate the coronavirus uncertainty and help portfolio companies pick up the pieces, whether that means cutting costs or realizing new revenue streams
Mongolia start-ups: Steppe forward
Unlike most frontiers, Mongolia is more talent hub than consumer market. There is no systemic hindrance to start-up investment but few mechanisms to sufficiently organize it
India technology: The Jio effect
Nearly three months have passed since Reliance Industries launched Jio Platforms as a holding company for its digital businesses. Is it poised to reshape India’s technology landscape?
Australia's Business Growth Fund: Policy props
The Australian government has accumulated $365 million for a fund that will support small businesses. Private equity investors are unsure why it’s necessary and how it will be managed
Australia IPOs: Suspicious minds
A handful of bad experiences have made Australia’s public market investors wary of private equity-backed IPOs. This doesn’t mean offerings can’t get done, but the industry must address its profile problem
Australia technology: Taking care of business
Investors are quietly leveraging subtle advantages in the Australian enterprise software space to create global leaders. The market will not remain an overlooked goldmine for long
Australia PE spinouts: Into the unknown
Australia has seen plenty of spinouts in recent years, with outcomes ranging from a $2 billion first-time fund to deal-by-deal strategies. Is local LP support essential in getting wider traction?
GP profile: DSG Consumer Partners
A relentless curiosity about the Indian consumer’s journey has helped DSG Consumer Partners carve out a niche in the early stage investment space for companies with emerging local brands
First responders: China VCs on a healthcare crisis
The coronavirus outbreak has thrust Chinese healthcare services into the spotlight, prompting investors to identify to sub-segments with potential for significant growth
Poor relations: Endowments and foundations in Asia
With a few exceptions, Asia’s endowments and foundations lack the scale, sophistication and appetite for alternatives of their US brethren. Structural and cultural barriers maintain the status quo
China space tech: Aligning the stars
SpaceX-inspired global fervor about the possibilities of space technology has infiltrated China. Some start-ups appear well set for commercial lift-off, but many others will misfire
Portfolio: Unison Capital and CHCP
Through its Community Healthcare Coordination Platform, Unison Capital wants to bring efficiencies and economies of scale to parts of Japan’s healthcare sector that have been isolated from private markets
VC and age: No industry for old men
The trendy, shape-shifting world of venture capital is broadly seen as a young person’s game, although hard evidence to this effect remains in scarce supply
India AIFs: A new phase
Locally domiciled Alternative Investment Funds have emerged as the structure of choice for India-focused private equity firms, but the system is still troubled by some imperfections
